
VP Technology @vedantabio. Interested in restoring and controlling the human microbiome.
Cambridge, MA
Joined May 2023
- Tweets350
- Following639
- Followers312
- Likes1.6K
Greg Medlock retweeted
NEW on the SPRIND 🎧 #Podcast:
What are microbial consortia? And what is the SPRIND challenge Engineering Microbial Consortia all about? Our host speaks with: Joe Meyerowitz, serial entrepreneur and mastermind behind our new challenge.
Episode #136 of the SPRIND Podcast.
Greg Medlock retweeted
We're hiring - come join our amazing community!
Faculty search in the Division of Experimental Pathology at @CHOP_Research
The successful candidate will hold a Penn faculty appointment, with full access to resources at both CHOP and Penn
Please share!
apply.interfolio.com/193339
Greg Medlock retweeted
NSF X-Labs is expanding pathways for institutions & teams to advance innovative science and tech critical to U.S. competitiveness. Today, NSF announces 3 new topics: AI for Physical Systems, From Sequence to Function, & Computation at the Limit of Physics.
brnw.ch/21x5JSo
Greg Medlock retweeted
The subject of the book is in the image.
At the centre, what science observes. Around it, what the market makes of it.
Between the two, a gap no one can measure any more, including, often, my own patients.
Greg Medlock retweeted
Ok, I love @Muse. Needs more integrations tho. Slack, X, iMessage — if it can make phone calls so I don’t have to talk to people for things that shouldn’t have ever needed a phone call, that would be epic
Greg Medlock retweeted
[1/6]
Every week I receive requests for fecal transplantation in diseases where there is no evidence at all.
Neurodegenerative disease. Fibromyalgia. Treatment-resistant depression. And sometimes, simply, general “wellness”.
Greg Medlock retweeted
In May, Vijeta and I had our wedding in Cambridge Commons with hundreds of you all.
In June, her grandfather suddenly passed away.
In July, her papa was diagnosed with stage IV cancer and a brain tumor. He is 58. He was at our wedding, already symptomatic, and none of us knew.
We thought we'd be planning a honeymoon. Instead life threw a heavy punch.
But we’re not ones to take a fight lying down. The honeymoon is on hold. We're cashing in our savings and going all in.
And still, we can't help being optimistic. We can't help trying hard. We’re hoping the standard treatment will lead to remission. But if need be, Burhan has said for years that if cancer is ever cured, it'll be cured in Kendall Square and make ourselves a small part of that story. We want to understand this disease as deeply as we can (we’ve been deeply moved by the stories of Sid Sijbrandij and Ben Sasse), and if we have to build a new treatment ourselves, that's what we'll do.
Before the clinical details, I want you to know who he is to Vijeta and us.
He held Vijeta for hours in the hospital the day she was born, just staring. He stood outside her school for six hours in the summer heat because she sneezed one morning in first grade. He took her to the park every single day for sixteen years. For 28 years he's walked his neighborhood checking on every old uncle, making sure none of them go without a friend. He's a professor whose students and colleagues fight for him in ways I've rarely seen even family manage.
Here's where we are.
Surgeons removed the tumor from his cerebellum on July 13 and he came through it well. It's metastasis. It's a cancer that started somewhere else in his body and traveled to his brain, and we don't know yet where it started. Treatment depends on knowing. And it's incredibly fast dividing. Every single day matters.
Right now we're starting radiation on the brain and hunting for the primary.
Vijeta is a researcher. I'm an engineer. We've spent the last four weeks reading everything we can find, and what we found was not despair.
Here's where you come in. Five things, and any one of them helps.
1. We have three tissue blocks from the surgery. One has been analyzed. One is at a genomics lab in Hyderabad running a full genomic profile. The third is unspent and we're holding it. If you know a lab that can run something those two won't, tell us.
2. If you've seen this before, a single brain metastasis with an unknown primary, we want your instinct. Assume we haven't heard of the thing you're about to suggest.
3. Introductions. Doctors, researchers, labs, clinical trials, anyone working on cancer of unknown primary.
4. If you have access to a frontier AI model, that’ll be helpful as we’re trying to get an incredible amount of data points and the processing power will be very helpful.
5. Share this on socials or forward this to the one person you know who might have an answer.
We're publishing all of it as we go. The scans, the pathology, the decisions, the reasoning behind the decisions, and the ones that turn out to be wrong. The full clinical detail is in the post below, including the immunohistochemistry panel.
vijetaandburhan.substack.com…
If you have answers, suggestions, introductions or anything else send us an email to: [email protected]
PS. I expect my City Council work and State Senate campaign to continue as normal. Vijeta, on the other hand, has taken an extended leave from her job. We expect to pay for most of this treatment out of pocket, and we're restructuring our lives around it as we go. Please have some grace with us while we do. We'd appreciate the kindness.
Minibwa is a hybrid of bwa-mem and minimap2 and the successor of bwa-mem for short-read mapping. ~4X/2.5X as fast as bwa-mem/bwa-mem2 for WGS reads at comparable accuracy. Native support of directional bisulfite-seq. Applicable to long reads. Preprint at arxiv.org/abs/2606.15357
Greg Medlock retweeted
Pleased to see out this paper in @Gut_BMJ on behalf of the @BritSocGastro Gut Microbiota for Health panel - taking stock of where we have come in the last decade in translating gut #microbiome research: gut.bmj.com/content/early/20… @IHepatology @ImperialMDR @eurfmt
Greg Medlock retweeted
Onwards!
Vedanta Biosciences Announces the Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection Will Continue as Planned Following Protocol-Specified Interim Analysis
Greg Medlock retweeted
For a Friday feed cleanser, this Afroman story is hysterical - and a win for the First Amendment!
An Ohio jury has found @ogafroman not liable for defaming the sheriff’s deputies who raided his house on a bogus tip.
Read more: reason.pub/4rKT9dE
Greg Medlock retweeted
We're searching for the next Director of the Duchossois Family Institute at UChicago
The most exciting leadership role in microbiome science right now: lead faculty, cutting-edge cores, an FDA-approved facility for microbiome therapeutics
Apply here: apply.interfolio.com/182203
Greg Medlock retweeted
Excited to share this preprint that describes my latest work on using GPUs to accelerate processing of RNA-seq data.
The title says it all: "RNA-seq analysis in seconds using GPUs" now on biorxiv biorxiv.org/content/10.64898…
Figure 1 shows they key result
Greg Medlock retweeted
Meet the 14 exceptional scientists and innovators who will define the next decade of breakthrough innovation as the @coeff_giving x Big if True Science Accelerator Americas cohort.
Here's what they're building: 🧵
1/15
Greg Medlock retweeted
Try our Estimate agent to get a ballpark on what it would cost to run your favorite protocol on Ginkgo Cloud Lab! It's pretty fun to play with.
cloud.ginkgo.bio/protocols
Fed a piece of protocol from the user manual of #PandaPure @AilurusBio for one-step, column-free protein purification and tag removal to the "EsiMate" of @Ginkgo recent cloud lab webpage.
The cost per sample is $40.52. Sounds not bad!
So you sequenced a billion+ bases. That don’t impress me much.
Over the last decade, biologists have learned how to generate genome sequences at extraordinary scale. What hasn’t kept pace is figuring out what those genes actually do.
Today we infer what a gene by computing similarities, whether by sequence or by structure. Incredibly useful for a first pass but not good enough in most cases to understand or engineer biology. You have to modify the genes and measure the consequences to know what they do.
JERBOA is a toolkit to figure out what genes do at scale. We've used it to unlock 43 non-model microbes across 12 different phyla.
Molecular assets on @Addgene. Analysis software on @github. There's so much to explore, get out there!!
Check out our latest work!
JERBOA, a toolkit for making genome-wide genetics work in non-model bacteria.
blog.cultivarium.org/p/so-yo…
Greg Medlock retweeted
Public safety is the first duty of government. ICE is not just failing to protect public safety in Minnesota – it is an active threat to it. The president must end this operation immediately and allow for a thorough investigation by state and local law enforcement.
Republicans in Congress must agree to Democrats' longstanding demands for root-level reform: disband the paramilitary that has ballooned over the last year, end masking & warrantless street-grabs, and train to the standards of due process and professionalism fitting a free people.
Greg Medlock retweeted
It’s World AMR Awareness Week! Watch the video below to hear CARB-X Chief of R&D Erin Duffy highlight the progress of the portfolio including interviews with product developers @dayzerodx and @VedantaBio. #WAAW
🔗 Watch here: bit.ly/48PfzTq



































